Viewing data from:

CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE

ANDA

BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | A210765 | COSETTE PHARMACEUTICALS NC LABORATORIES LLC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: TACLONEX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$1.30

per gm

Lowest NADAC/Unit

$1.21

per gm

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00713084860CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION	$1.30	GM	Generic	—	2026-06-17
00713084892CALCIPOTRIENE-BETAMETHASONE DP 0.005%-0.064% SUSPENSION	$1.21	GM	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$485.56

Highest Price

$971.13

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00713-0848-60BETAMETHASONE DIPROPIONATE 0.064%/CALCIPOTRIE	$485.56	FSS	Cosette Pharmaceutical, Inc.	08/14/2027
00713-0848-92BETAMETHASONE DIPROPIONATE 0.064%/CALCIPOTRIE	$971.13	FSS	Cosette Pharmaceutical, Inc.	08/14/2027

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 4, 2020	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.064%;0.005%

0 patents0 exclusivities▴

SUSPENSION;TOPICAL | Approved: May 11, 2020

No patent or exclusivity listings for this strength.